ONCO
Price:
$0.6602
Market Cap:
$2.26M
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cinci...[Read more]
Industry
Biotechnology
IPO Date
2022-02-18
Stock Exchange
NASDAQ
Ticker
ONCO
According to Onconetix, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.41% compared to the average of -1.69 of the last 4 quarters.
The mean historical PE Ratio of Onconetix, Inc. over the last ten years is -3386.67. The current -0.01 PE Ratio has changed -99.97% with respect to the historical average. Over the past ten years (40 quarters), ONCO's PE Ratio was at its highest in in the December 2025 quarter at 1.13. The PE Ratio was at its lowest in in the September 2021 quarter at -2531.27.
Average
-3386.67
Median
-17.60
Minimum
-13500.56
Maximum
-0.52
Discovering the peaks and valleys of Onconetix, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 253.72%
Maximum Annual PE Ratio = -0.52
Minimum Annual Increase = -99.46%
Minimum Annual PE Ratio = -13500.56
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.82 | 253.72% |
| 2024 | -0.52 | -67.45% |
| 2023 | -1.58 | -91.00% |
| 2022 | -17.60 | -99.46% |
| 2021 | -3247.07 | -53.20% |
| 2020 | -6937.51 | -48.61% |
The current PE Ratio of Onconetix, Inc. (ONCO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.31
5-year avg
-653.72
10-year avg
-3386.67
Onconetix, Inc.’s PE Ratio is greater than Jasper Therapeutics, Inc. (-0.24), greater than Azitra, Inc. (-0.12), greater than Revelation Biosciences, Inc. (-0.08), greater than Scinai Immunotherapeutics Ltd. (-0.20), greater than SciSparc Ltd. (-0.04), greater than Indaptus Therapeutics, Inc. (-0.31), greater than Enveric Biosciences, Inc. (-0.48), greater than Silexion Therapeutics Ltd. (-0.16), greater than Protagenic Therapeutics, Inc. (-0.33), greater than Salarius Pharmaceuticals, Inc. (-0.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.24 | $15.12M | |
| -0.12 | $2.81M | |
| -0.08 | $4.24M | |
| -0.20 | $933.91K | |
| -0.04 | $507.28K | |
| -0.31 | $5.22M | |
| -0.48 | $2.38M | |
| -0.16 | $344.99K | |
| -0.33 | $1.59M | |
| -0.21 | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Onconetix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Onconetix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Onconetix, Inc.'s PE Ratio?
How is the PE Ratio calculated for Onconetix, Inc. (ONCO)?
What is the highest PE Ratio for Onconetix, Inc. (ONCO)?
What is the 3-year average PE Ratio for Onconetix, Inc. (ONCO)?
What is the 5-year average PE Ratio for Onconetix, Inc. (ONCO)?
How does the current PE Ratio for Onconetix, Inc. (ONCO) compare to its historical average?